A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and
Safety of Intravitreal OPT-302 in Combination with Aflibercept, Compared with
Aflibercept Alone, in Participants with Neovascular Age-related Macular Degeneration
(nAMD)
A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and
Safety of Intravitreal OPT-302 in Combination with Aflibercept, Compared with
Aflibercept Alone, in Participants with Neovascular Age-related Macular Degeneration
(nAMD)
A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and
Safety of Intravitreal OPT-302 in Combination with Aflibercept, Compared with
Aflibercept Alone, in Participants with Neovascular Age-related Macular Degeneration
(nAMD)
A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and
Safety of Intravitreal OPT-302 in Combination with Aflibercept, Compared with
Aflibercept Alone, in Participants with Neovascular Age-related Macular Degeneration
(nAMD)
A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and
Safety of Intravitreal OPT-302 in Combination with Aflibercept, Compared with
Aflibercept Alone, in Participants with Neovascular Age-related Macular Degeneration
(nAMD)
A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and
Safety of Intravitreal OPT-302 in Combination with Aflibercept, Compared with
Aflibercept Alone, in Participants with Neovascular Age-related Macular Degeneration
(nAMD)
A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and
Safety of Intravitreal OPT-302 in Combination with Aflibercept, Compared with
Aflibercept Alone, in Participants with Neovascular Age-related Macular Degeneration
(nAMD)
A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and
Safety of Intravitreal OPT-302 in Combination with Aflibercept, Compared with
Aflibercept Alone, in Participants with Neovascular Age-related Macular Degeneration
(nAMD)
A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and
Safety of Intravitreal OPT-302 in Combination with Aflibercept, Compared with
Aflibercept Alone, in Participants with Neovascular Age-related Macular Degeneration
(nAMD)
A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and
Safety of Intravitreal OPT-302 in Combination with Aflibercept, Compared with
Aflibercept Alone, in Participants with Neovascular Age-related Macular Degeneration
(nAMD)
A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and
Safety of Intravitreal OPT-302 in Combination with Aflibercept, Compared with
Aflibercept Alone, in Participants with Neovascular Age-related Macular Degeneration
(nAMD)
A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and
Safety of Intravitreal OPT-302 in Combination with Aflibercept, Compared with
Aflibercept Alone, in Participants with Neovascular Age-related Macular Degeneration
(nAMD)
A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and
Safety of Intravitreal OPT-302 in Combination with Aflibercept, Compared with
Aflibercept Alone, in Participants with Neovascular Age-related Macular Degeneration
(nAMD)
A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and
Safety of Intravitreal OPT-302 in Combination with Aflibercept, Compared with
Aflibercept Alone, in Participants with Neovascular Age-related Macular Degeneration
(nAMD)
A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and
Safety of Intravitreal OPT-302 in Combination with Aflibercept, Compared with
Aflibercept Alone, in Participants with Neovascular Age-related Macular Degeneration
(nAMD)
A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and
Safety of Intravitreal OPT-302 in Combination with Aflibercept, Compared with
Aflibercept Alone, in Participants with Neovascular Age-related Macular Degeneration
(nAMD)
A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and
Safety of Intravitreal OPT-302 in Combination with Aflibercept, Compared with
Aflibercept Alone, in Participants with Neovascular Age-related Macular Degeneration
(nAMD)
A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and
Safety of Intravitreal OPT-302 in Combination with Aflibercept, Compared with
Aflibercept Alone, in Participants with Neovascular Age-related Macular Degeneration
(nAMD)
A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and
Safety of Intravitreal OPT-302 in Combination with Aflibercept, Compared with
Aflibercept Alone, in Participants with Neovascular Age-related Macular Degeneration
(nAMD)
A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and
Safety of Intravitreal OPT-302 in Combination with Aflibercept, Compared with
Aflibercept Alone, in Participants with Neovascular Age-related Macular Degeneration
(nAMD)